Van Lanschot Kempen Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Van Lanschot Kempen Investment Management's LLY Position: Q1 2026 in Review
Van Lanschot Kempen Investment Management reduced its Eli Lilly (LLY) stake by 9.9% in Q1 2026, selling an estimated $5.1M and leaving 45,972 shares worth $42.3M. The position accounts for 0.37% of the portfolio, ranked #46.
Van Lanschot Kempen Investment Management first reported a position in LLY in Q4 2013 and has held it in 18 quarters since. The position peaked at $54.8M in Q4 2025. 4,359 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Van Lanschot Kempen Investment Management held 45,972 shares of Eli Lilly worth $42.3M as of Q1 2026.
- Van Lanschot Kempen Investment Management sold 5,026 Eli Lilly shares in Q1 2026, an estimated $5.1M.
- Eli Lilly made up 0.37% of Van Lanschot Kempen Investment Management's portfolio in Q1 2026, its #46 holding.
- Van Lanschot Kempen Investment Management first reported a position in Eli Lilly in Q4 2013 and has held it in 18 quarters since.
- Van Lanschot Kempen Investment Management's Eli Lilly position peaked at $54.8M in Q4 2025.
- 4,359 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Van Lanschot Kempen Investment Management's 13F filing for Q1 2026, filed 15 May 2026.